Genentech Archives -

RNAi biotech Atalanta debuts with $110m plus Biogen and Roche CNS tie-ups

https://pharmaphorum.com/news/rnai-biotech-atalanta-debuts-with-110m-plus-biogen-and-roche-cns-tie-ups/

AC Immune poleaxed on Alzheimer’s study fail

https://pharmaphorum.com/news/ac-immune-poleaxed-on-alzheimers-study-fail/

Amgen’s cancer biosimilars stay on US market as court battle with Roche ends

https://pharmaphorum.com/news/amgens-cancer-biosimilars-stay-on-us-market-as-court-battle-with-roche-ends/

Roche hops on Bicycle’s drug discovery platform for cancer

https://pharmaphorum.com/news/roche-hops-on-bicycles-drug-discovery-platform-for-cancer/

The promise and pitfalls of molecular testing in oncology

https://deep-dive.pharmaphorum.com/magazine/oncology-asco-2019/research-partnership-molecular-testing-cancer/

Genentech extends small-molecule R&D with three platform deals

https://pharmaphorum.com/news/genentech-extends-small-molecule-rd-with-three-platform-deals/

Roche and AbbVie’s Venclexta approved in CLL

https://pharmaphorum.com/news/roche-and-abbvies-venclexta-approved-in-cll/

Genentech brings back Alexander Hardy to take CEO position

https://pharmaphorum.com/news/genentech-brings-back-alexander-hardy-ceo-position/

Affimed and Roche ink $5bn plus cancer immunotherapy deal

https://pharmaphorum.com/news/affimed-and-roche-ink-5bn-plus-cancer-immunotherapy-deal/

Search